The Provider Support Initiative Presents: Treating Hepatitis C and Opioid Use Disorder

Thursday, December 10, 2020, 12:00 PM - Thursday, September 29, 2022, 1:00 PM PST, Online

People who use drugs have a high prevalence of hepatitis C virus (HCV) and significant morbidity associated with drug use, especially when injection drug use is involved. This webinar will address the connections between HCV, opioid use disorder (OUD), and other drug use-related harms, as well as effective treatments for HCV and OUD.

Release Date: February 19, 2021
Expiration Date: September 29, 2022
Estimated Time to Complete: 1 hour
Registration Fee: FREE

Recorded on October 13, 2020

AMA PRA Category 1 Credits™ (1.00 hours), Non-Physician Participation Credit (1.00 hours)

1. Identify two (2) viral and two (2) bacterial infections associated with injection drug use.
2. Describe the difference between the disease expression and treatment of Hepatitis A and B.
3. Implement strategies to integrate HIV and HCV education into your opioid safety efforts.

In support of improving patient care, Stanford Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation

American Medical Association (AMA)
Stanford Medicine designates this Enduring Material for a maximum of 1.00 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Bibliography
Provider Resources: http://www.uclaisap.org/ca-hubandspoke/html/provider-resources.html
Factsheets and Toolkits: http://uclaisap.org/MATPrescriberSupport/html/factsheets-toolkits.html

Accessibility Statement
 Stanford University School of Medicine is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008.  If you have needs that require special accommodations, including dietary concerns, please contact the CME Conference Coordinator.

Cultural and Linguistic Competency
The planners and speakers of this CME activity have been encouraged to address cultural issues relevant to their topic area for the purpose of complying with California Assembly Bill 1195. Moreover, the Stanford University School of Medicine Multicultural Health Portal contains many useful cultural and linguistic competency tools including culture guides, language access information and pertinent state and federal laws.  You are encouraged to visit the Multicultural Health Portal: https://laneguides.stanford.edu/multicultural-health

For CME general questions, please contact 
     Ph: (650)-497-8554
     Email: [email protected]

The Stanford University School of Medicine adheres to ACCME Criteria, Standards and Policies regarding industry support of continuing medical education.

There are no relevant financial relationships with ACCME-defined commercial interests for anyone who was in control of the content of this activity.